Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Director departure Appointed director
|
WORLD HEART CORP (WHRT)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/02/2012 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs:
|
"Amended and Restated Certificate of Incorporation of World Heart Corporation",
"Amended and Restated Bylaws of World Heart Corporation",
"HEARTWARE COMPLETES ACQUISITION OF WORLD HEART CORPORATION Framingham, Mass. and Salt Lake City, Utah, August 2, 2012 - HeartWare International, Inc. , a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced the closing of the acquisition of World Heart Corporation following the approval of the transaction today by World Heart stockholders. Under the terms of the merger agreement, HeartWare acquired all of the outstanding voting securities of World Heart for merger consideration of approximately $8,000,000 in HeartWare common stock, as calculated in accordance with the terms of the merger agreement. Each share of World Heart common stock has been converted into the right to receive..." |
|
07/02/2012 |
8-K
| Quarterly results |
04/24/2012 |
8-K
| Form 8-K - Current report |
04/03/2012 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs:
|
"Agreement and Plan of Merger, by and among HeartWare International, Inc., Ocean Acquisition Holding Inc. and World Heart Corporation",
"Form of Voting Agreement entered into between HeartWare International, Inc., Ocean Acquisition Holding Inc. and the following stockholders of World Heart Corporation: Austin W. Marxe, New Leaf Ventures II, L.P., Venrock Associates V, L.P., Venrock Partners V, L.P. and Venrock Entrepreneurs Fund V, L.P",
"License Agreement, by and between World Heart Corporation and HeartWare International, Inc" |
|
02/23/2012 |
8-K
| Form 8-K - Current report |
08/18/2011 |
8-K
| Form 8-K - Current report |
07/29/2011 |
8-K
| Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm... |
06/28/2011 |
8-K
| Submission of Matters to a Vote of Security Holders |
02/14/2011 |
8-K
| Form 8-K - Current report |
02/09/2011 |
8-K
| Form 8-K - Current report |
01/12/2011 |
8-K
| Form 8-K - Current report |
12/06/2010 |
8-K
| Other Events, Financial Statements and Exhibits |
10/20/2010 |
8-K
| Form 8-K - Current report |
10/14/2010 |
8-K
| Form 8-K - Current report |
08/16/2010 |
8-K
| Form 8-K - Current report |
08/03/2010 |
8-K
| Other Events, Financial Statements and Exhibits |
07/27/2010 |
8-K
| Other Events, Financial Statements and Exhibits |
07/06/2010 |
8-K
| Form 8-K - Current report |
06/21/2010 |
8-K
| Other Events, Financial Statements and Exhibits |
06/16/2010 |
8-K
| Form 8-K - Current report |
06/14/2010 |
8-K
| Submission of Matters to a Vote of Security Holders |
05/17/2010 |
8-K
| Quarterly results
Docs:
|
"WorldHeart Reports First Quarter 2010 Financial Results Status of the Bridge-to-Transplant Clinical Study and Field Corrective Action Salt Lake City, UT — May 17, 2010: World Heart Corporation , a developer of mechanical circulatory systems, today reported its results for the first quarter 2010. WorldHeart reported a net loss for the three months ended March 31, 2010 of $9.7 million, or a $0.68 loss per basic and diluted share, compared to a $3.7 million net loss, or a $0.28 loss per basic and diluted share for the same period in 2009. The increase in net loss and loss per share for the three months ended March 31, 2010 as compared to the same period on 2009 was primarily the result of a one-time, non-cash loss on liquidation of foreign entity of $6.3 million as a result of WorldHeart's ch..." |
|
05/03/2010 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
04/13/2010 |
8-K
| Form 8-K - Current report |
03/23/2010 |
8-K
| Other Events, Financial Statements and Exhibits |
03/09/2010 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
03/01/2010 |
8-K
| Quarterly results |
02/10/2010 |
8-K
| Form 8-K - Current report |
02/05/2010 |
8-K
| Appointed a new director |
02/04/2010 |
8-K
| Other Events, Financial Statements and Exhibits |
01/22/2010 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
01/19/2010 |
8-K
| Other Events, Financial Statements and Exhibits
Docs:
|
"WorldHeart Announces First U.S. Implant of Levacor™ VAD Implant at INTEGRIS in Oklahoma City SALT LAKE CITY, January 19, 2010 — World Heart Corporation , a developer of mechanical circulatory systems, announced today that the first U.S. implant of the Levacor Ventricular Assist Device was successfully performed at INTEGRIS Baptist Medical Center in Oklahoma City on Wednesday, January 13, 2010. This is the first implant in the Levacor VAD bridge-to-transplant study, which is expected to enroll 160 patients, pursuant to a recently approved U.S. Investigational Device Exemption Application. INTEGRIS is the first of the initial ten BTT clinical study sites. The recipient, an Oklahoma native, is a 59- year-old woman suffering from severe cardiomyopathy, or a weakened heart muscle. Dr. Craig Elk..." |
|
01/08/2010 |
8-K
| Form 8-K - Current report |
01/04/2010 |
8-K
| Form 8-K - Current report |
|
|
|